Omega Healthcare Investors Inc

1. 1

   Election of Directors

   ManagementBoard: FOR

   Election of eight incumbent directors (Craig R. Callen, Kapila K. Anand, Dr. Lisa C. Egbuonu-Davis, Barbara B. Hill, Kevin J. Jacobs, C. Taylor Pickett, Stephen D. Plavin, Burke W. Whitman) to hold office until the 2027 Annual Meeting.

2. 2

   Ratification of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Year Ending December 31, 2026

   ManagementBoard: FOR

   Ratify the Audit Committee’s selection of Ernst & Young LLP as the company’s independent registered public accounting firm for fiscal year 2026.

   More detail

   The proposal asks shareholders to ratify the Audit Committee’s selection of EY as the company’s independent registered public accounting firm for fiscal year 2026. Management is seeking shareholder approval as a matter of good corporate governance, even though the Audit Committee has sole authority to appoint the auditor. The proxy explains EY’s long tenure since 1992, the Audit Committee’s process, fees paid, and its conclusion that EY’s services were compatible with maintaining independence. The Board and Audit Committee recommend a vote FOR, citing EY’s professional qualifications, industry experience, and institutional knowledge. A failure to ratify would prompt the Audit Committee to reconsider its selection. The proposal is routine and non-controversial, focusing on auditor oversight, independence, and continuity.

3. 3

   Advisory Vote to Approve Named Executive Officer Compensation (Say-on-Pay

   ManagementBoard: FOR

   Non-binding, advisory vote to approve the compensation of the company’s named executive officers as described in the proxy statement (say-on-pay).

   More detail

   This management-sponsored advisory proposal asks shareholders to approve, on a non-binding basis, the compensation of the company’s named executive officers as disclosed in the proxy. Management seeks annual ratification to demonstrate alignment with shareholders and to validate its pay-for-performance design: a mix of short-term cash incentives tied to FAD per share, tenant quality and leverage and longer-term equity awards tied to absolute and relative TSR. The Board recommends a vote FOR, citing high prior-year shareholder support (95.9% in 2025) and asserting that the program attracts and retains talent while aligning pay with long-term stockholder value. As an advisory vote, the outcome isn’t binding, but the Compensation Committee will consider results when setting future pay. The proposal raises governance considerations about executive pay, but in this filing management frames the program as rigorous and aligned with shareholder interests.

Upcoming shareholder meetings at Omega Healthcare Investors Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.

When is the Omega Healthcare Investors Inc 2026 annual meeting?

Omega Healthcare Investors Inc (OHI) holds its 2026 annual shareholder meeting on Friday, June 5, 2026.

What is the record date for the Omega Healthcare Investors Inc 2026 meeting?

The record date for the Omega Healthcare Investors Inc 2026 meeting is Wednesday, April 8, 2026. Shareholders of record on or before that date are eligible to vote.

Who are the director nominees for Omega Healthcare Investors Inc's 2026 meeting?

The board is presenting 8 director nominees at the Omega Healthcare Investors Inc 2026 meeting, listed with their independence status and background.

What proposals will shareholders vote on at the Omega Healthcare Investors Inc 2026 meeting?

Shareholders will vote on 3 proposals at the Omega Healthcare Investors Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.